No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Atelectasis is a condition in which the air sacs in the lungs collapse or become deflated, resulting in difficulty breathing. Respiratory drugs are used to treat this condition, as well as other respiratory diseases such as asthma, COPD, and cystic fibrosis. These drugs can be divided into two main categories: bronchodilators and anti-inflammatory agents. Bronchodilators are used to open up the airways and reduce airway resistance, while anti-inflammatory agents reduce inflammation in the airways.
The atelectasis drug market is a subset of the larger respiratory drug market. It includes drugs that are specifically designed to treat atelectasis, as well as those that are used to treat other respiratory diseases that can lead to atelectasis. These drugs are used to reduce airway resistance, reduce inflammation, and improve lung function.
Some companies in the atelectasis drug market include GlaxoSmithKline, AstraZeneca, Merck, and Boehringer Ingelheim. Show Less Read more
